IRCT20220107053652N1
Completed
未知
Evaluation of the effect of metformin and insulin combination therapy in comparison with the use of insulin alone in the prevention of preeclampsia in pregnant women with gestational diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Gestational diabetes
- •Age of 18\-40 years
- •Single pregnancy
- •Gestational age between 20\-34 weeks
- •Fasting glucose test more than 95 mg/dl or 2 hours postprandial glucose more than 120 mg
Exclusion Criteria
- •Having high blood pressure before pregnancy
- •Previous history of any systemic disease (including cardiovascular, renal, hepatic, and autoimmune diseases)
- •Addiction and drug abuse
- •Obesity (Body mass index above 30\)
- •Overt diabetes
- •Major neonatal malformations
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Comparing the effect of metformin with insulin on gestational diabetesIRCT20080826001096N9Rasht University of Medical Sciences132
Completed
Phase 3
Comparing the effect of metformin versus insulin in controlling the blood sugar in of gestational diabetic motherGestational diabetes mellitus.Diabetes mellitus arising in pregnancyIRCT2016080229172N1Vice Chancellor for Research of Mashhad University of Medical Sciences280
Recruiting
Not Applicable
Comparision metformin and insulin for treatment of diabetes gestationalGestational diabetesJPRN-UMIN000005393Sao Paulo University - Brazil200
Completed
Not Applicable
The Comparison of the effects of metformin and insulin in the treatment of hyperglycemiaCondition 1: Hyperglycemia after coronary artery bypass surgery. Condition 2: Hyperglycaemia.Other functional disturbances following cardiac surgeryHyperglycaemia, unspecifiedIRCT2015072311399N2Vice chancellor for research, Semnan University of Medical Sciences60
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50